Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Income Statements (unaudited)

v3.23.3
Condensed Consolidated Income Statements (unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenues:    
Total revenues $ 28,300,820 $ 22,236,751
Cost of revenues:    
Total cost of revenues 2,474,685 2,110,984
Selling and marketing expenses 4,160,244 3,287,488
Depreciation and amortization 2,215,055 1,336,656
General and administrative expenses 20,038,476 15,533,426
Total selling, general and administrative expenses 26,413,775 20,157,570
Net loss on disposition or impairment 65,469 6,906
Loss from operations (653,109) (38,709)
Other income (expense), net 3,821,162 (16,147)
Income (loss) before income tax benefit 3,168,053 (54,856)
Income tax expense 841,889 (59,076)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total $ 2,326,164 $ 4,220
Earnings (loss) per share:    
Basic (loss) earnings per share (in dollars per share) $ 0.16 $ 0
Diluted (loss) earnings per share (in dollars per share) $ 0.16 $ 0
Basic weighted average shares (in shares) 14,566,185 14,432,652
Diluted weighted average shares (in shares) 14,861,734 14,432,652
Revenues from company-owned or managed clinics    
Revenues:    
Total revenues $ 17,127,957 $ 12,606,999
Royalty fees    
Revenues:    
Total revenues 6,866,023 6,008,932
Franchise fees    
Revenues:    
Total revenues 754,425 640,965
Cost of revenues:    
Cost of revenues 2,140,835 1,801,026
Advertising fund revenue    
Revenues:    
Total revenues 1,952,406 1,710,717
Software fees    
Revenues:    
Total revenues 1,210,005 956,998
Cost of revenues:    
Cost of revenues 333,850 309,958
Regional developer fees    
Revenues:    
Total revenues 0 0
Other revenues    
Revenues:    
Total revenues $ 390,004 $ 312,140